IPO
PaxMedica, Inc.
Biopharmaceutical
Early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism spectrum disorder (or ASD), and Fragile X tremor-ataxia syndrome (or FXTAS).
Symbol
PXMD
Price Range
$5.50 - $6.50
Anticipated Date
October 9, 2020
Underwriters
THE BENCHMARK COMPANY, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for PaxMedica, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277